Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - DE
$ 5.44
6.67 %
$ 1.93 B
Market Cap
-9.89
P/E
Price Target
Average
83.82%
Revenue Forecast
Estimate
17.37%
EBIT
Estimate
18.93%
Net Income
Estimate
26.72%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Evotec SE
Wall Street analysts predict an average 1-year price target for EVO of $10 , with forecasts ranging from a low of $8 to a high of $12 .
EVO Lowest Price Target
Wall Street Target
8 USD
47.06%
EVO Average Price Target
Wall Street Target
10 USD
83.82%
EVO Highest Price Target
Wall Street Target
12 USD
120.59%
REVENUE FORECAST
Revenue Forecast Chart EVO
EBIT FORECAST
EBIT Forecast Chart EVO
NET INCOME FORECAST
Net Income Chart EVO